Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study
Acta Neuropathologica · 2024-06 · 147 (1)
DOI: 10.1007/s00401-023-02660-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 30.12.2023. Verfasst von Laia Montoliu-Gaya und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölnd…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, CSRD VA.
Themen: Demenz
Abstract (Originalsprache)
Plasma-to-autopsy studies are essential for validation of blood biomarkers and understanding their relation to Alzheimer’s disease (AD) pathology. Few such studies have been done on phosphorylated tau (p-tau) and those that exist have made limited or no comparison of the different p-tau variants. This study is the first to use immunoprecipitation mass spectrometry (IP-MS) to compare the accuracy of eight different plasma tau species in predicting autopsy-confirmed AD. The sample included 123 participants (AD = 69, non-AD = 54) from the Boston University Alzheimer’s disease Research Center who had an available ante-mortem plasma sample and donated their brain. Plasma samples proximate to death were analyzed by targeted IP-MS for six different tryptic phosphorylated (p-tau-181, 199, 202, 205, 217, 231), and two non-phosphorylated tau (195–205, 212–221) peptides. NIA-Reagan Institute criteria were used for the neuropathological diagnosis of AD. Binary logistic regressions tested the association between each plasma peptide and autopsy-confirmed AD status. Area under the receiver operating curve (AUC) statistics were generated using predicted probabilities from the logistic regression models. Odds Ratio (OR) was used to study associations between the different plasma tau species and CERAD and Braak classifications. All tau species were increased in AD compared to non-AD, but p-tau217, p-tau205 and p-tau231 showed the highest fold-changes. Plasma p-tau217 (AUC = 89.8), p-tau231 (AUC = 83.4), and p-tau205 (AUC = 81.3) all had excellent accuracy in discriminating AD from non-AD brain donors, even among those with CDR < 1). Furthermore, p-tau217, p-tau205 and p-tau231 showed the highest ORs with both CERAD (OR p-tau217 = 15.29, OR p-tau205 = 5.05 and OR p-tau231 = 3.86) and Braak staging (OR p-tau217 = 14.29, OR p-tau205 = 5.27 and OR p-tau231 = 4.02) but presented increased levels at different amyloid and tau stages determined by neuropathological examination. Our findings support plasma p-tau217 as the most promising p-tau species for detecting AD brain pathology. Plasma p-tau231 and p-tau205 may additionally function as markers for different stages of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. laia.montoliu.gaya@gu.se.
- Boston University Alzheimer's Disease Research Center and CTE Center, Boston University, Chobanian and Avedisian School of Medicine, Boston, MA, 02118, USA.
- Department of Neurology, Boston University, Chobanian and Avedisian School of Medicine, Boston, MA, 02118, USA.
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02118, USA.
- University of Arizona, Tucson, AZ, USA.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
ORCID-Profile: Laia Montoliu-Gaya
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- CSRD VA
- BLRD VA
- University of Gothenburg
Zitieren
APA
Montoliu-Gaya, L., Alosco, M. L., Yhang, E., Tripodis, Y., Sconzo, D., Ally, M., Grötschel, L., Ashton, N. J., Lantero-Rodriguez, J., Sauer, M., Gomes, B., Nilsson, J., Brinkmalm, G., Sugarman, M. A., Aparicio, H. J., Martin, B., Palmisano, J. N., Steinberg, E. G., Simkin, I., …, & Blennow, K. (2024). Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-023-02660-3
Vancouver
Montoliu-Gaya L, Alosco ML, Yhang E, Tripodis Y, Sconzo D, Ally M, et al. Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study. Acta Neuropathologica. 2024;147(1). doi:10.1007/s00401-023-02660-3
BibTeX
@article{MontoliuGaya2024,
author = {Montoliu-Gaya, Laia and Alosco, Michael L and Yhang, Eukyung and Tripodis, Yorghos and Sconzo, Daniel and Ally, Madeline and Grötschel, Lana and Ashton, Nicholas J and Lantero-Rodriguez, Juan and Sauer, Mathias and Gomes, Bárbara and Nilsson, Johanna and Brinkmalm, Gunnar and Sugarman, Michael A and Aparicio, Hugo J and Martin, Brett and Palmisano, Joseph N and Steinberg, Eric G and Simkin, Irene and Turk, Katherine W and Budson, Andrew E and Au, Rhoda and Farrer, Lindsay and Jun, Gyungah R and Kowall, Neil W and Stern, Robert A and Goldstein, Lee E and Qiu, Wei Qiao and Mez, Jesse and Huber, Bertrand Russell and Alvarez, Victor E and McKee, Ann C and Zetterberg, Henrik and Gobom, Johan and Stein, Thor D and Blennow, Kaj},
title = {Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study},
journal = {Acta Neuropathologica},
year = {2024},
volume = {147},
number = {1},
doi = {10.1007/s00401-023-02660-3}
}
EUVIMED